Reuters logo
BRIEF-Aurobindo Pharma gets USFDA approval for drug for treating chronic kidney disease
June 15, 2017 / 4:55 AM / 6 months ago

BRIEF-Aurobindo Pharma gets USFDA approval for drug for treating chronic kidney disease

June 15 (Reuters) - Aurobindo Pharma Ltd

* Aurobindo Pharma - receives USFDA approval for Sevelamer Carbonate Oral Suspension

* Aurobindo Pharma - product is being launched immediately

* Aurobindo Pharma - drug used for treatment of patients with chronic kidney disease Source text: (bit.ly/2rtQcVI) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below